CHP
FLXN

Cable Hill Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Cable Hill Partners’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-500
Closed -$13K – 910
2018
Q2 		$13K Sell
500
-250
-33% -$6.49K 0.01% 425
2018
Q1 		$18K Sell
750
-250
-25% -$6.1K 0.01% 375
2017
Q4 		$26K Buy
1,000
+500
+100% +$12.2K 0.01% 339
2017
Q3 		$12K Buy
+500
New +$11.8K 0.01% 538

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Cable Hill Partners's FLXN Position: Q3 2018 in Review

Cable Hill Partners sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2018, closing a stake of 500 shares — an estimated $13K sold.

Cable Hill Partners first reported a position in FLXN in Q3 2017 and held it in 4 quarters. The position peaked at $26K in Q4 2017. 129 funds tracked by Wall St. Rank hold FLXN as of Q3 2018.

  • Cable Hill Partners reported no remaining Flexion Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Cable Hill Partners sold 500 Flexion Therapeutics, Inc. shares in Q3 2018, an estimated $13K.
  • Cable Hill Partners first reported a position in Flexion Therapeutics, Inc. in Q3 2017 and held it in 4 quarters.
  • Cable Hill Partners's Flexion Therapeutics, Inc. position peaked at $26K in Q4 2017.
  • 129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2018.

Based on Cable Hill Partners's 13F filing for Q3 2018, filed 14 Nov 2018.